Literature DB >> 11561061

Identification and localization of five CYP2Cs in murine extrahepatic tissues and their metabolism of arachidonic acid to regio- and stereoselective products.

C C Tsao1, S J Coulter, A Chien, G Luo, N P Clayton, R Maronpot, J A Goldstein, D C Zeldin.   

Abstract

The CYP2C subfamily has been extensively studied in humans with respect to the metabolism of clinically important drugs, and polymorphisms have been identified in these enzymes. In the present study, a murine model was used to determine the possible physiological functions and extrahepatic distribution of CYP2Cs. Using the reverse transcription-polymerase chain reaction (RT-PCR), Western blotting, and immununohistochemistry, this report demonstrates that the mouse CYP2Cs are extensively distributed in extrahepatic tissues and localized to heart muscle, lung Clara and ciliated cells, kidney collecting ducts, the X-zone of female adrenals, reproductive organs, white blood cells, and eyes (in the optic nerve, rods, and cones). RT-PCR, subcloning, and sequencing of the products indicate that each CYP2C has a unique tissue distribution. Four cDNA fragments representing potentially new CYP2Cs were identified, each with its own organ-specific pattern of expression. Using a bacterial cDNA expression system, we found that recombinant proteins for each of the five full-length murine CYP2Cs metabolize arachidonic acid to different regio- and stereospecific products, including epoxyeicosatrienoic acids and hydroxyeicosatetraenoic acids. Regio- and stereospecific metabolites of arachidonic acid have been reported to affect important physiological functions such as inflammation, neutrophil activation, ion transport, cellular proliferation, and vascular tone. Our results suggest that the presence of CYP2C enzymes in heart muscle, aorta, kidney, lung, adrenals, eyes, and reproductive organs could regulate important physiological and/or pathological processes in these tissues.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11561061

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  17 in total

1.  Loss of orally administered drugs in GI tract.

Authors:  Yogeshkumar Nanasaheb Gavhane; Adhikrao Vyankatrao Yadav
Journal:  Saudi Pharm J       Date:  2012-04-20       Impact factor: 4.330

2.  A comprehensive investigation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) metabolism in the mouse using a multivariate data analysis approach.

Authors:  Chi Chen; Xiaochao Ma; Michael A Malfatti; Kristopher W Krausz; Shioko Kimura; James S Felton; Jeffrey R Idle; Frank J Gonzalez
Journal:  Chem Res Toxicol       Date:  2007-02-06       Impact factor: 3.739

3.  Cytochrome P450 Oxidase 2C Inhibition Adds to ω-3 Long-Chain Polyunsaturated Fatty Acids Protection Against Retinal and Choroidal Neovascularization.

Authors:  Yan Gong; Zhongjie Fu; Matthew L Edin; Chi-Hsiu Liu; Zhongxiao Wang; Zhuo Shao; Thomas W Fredrick; Nicholas J Saba; Peyton C Morss; Samuel B Burnim; Steven S Meng; Fred B Lih; Kin Sing Stephen Lee; Elizabeth P Moran; John Paul SanGiovanni; Ann Hellström; Bruce D Hammock; Darryl C Zeldin; Lois E H Smith
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-07-14       Impact factor: 8.311

4.  CYP2C29 produces superoxide in response to shear stress.

Authors:  Dong Sun; Caroline Ojaimi; Hongyan Wu; Gabor Kaley; An Huang
Journal:  Microcirculation       Date:  2012-11       Impact factor: 2.628

Review 5.  Epoxides and soluble epoxide hydrolase in cardiovascular physiology.

Authors:  John D Imig
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 37.312

Review 6.  Eicosanoid signalling pathways in the heart.

Authors:  Christopher M Jenkins; Ari Cedars; Richard W Gross
Journal:  Cardiovasc Res       Date:  2008-12-14       Impact factor: 10.787

7.  Midazolam metabolism in cytochrome P450 3A knockout mice can be attributed to up-regulated CYP2C enzymes.

Authors:  Robert A B van Waterschoot; Antonius E van Herwaarden; Jurjen S Lagas; Rolf W Sparidans; Els Wagenaar; Cornelia M M van der Kruijssen; Joyce A Goldstein; Darryl C Zeldin; Jos H Beijnen; Alfred H Schinkel
Journal:  Mol Pharmacol       Date:  2007-12-21       Impact factor: 4.436

8.  Possible mediators of connecting tubule glomerular feedback.

Authors:  YiLin Ren; Martin A D'Ambrosio; Jeffrey L Garvin; Hong Wang; Oscar A Carretero
Journal:  Hypertension       Date:  2008-12-01       Impact factor: 10.190

9.  Epoxyeicosatrienoic acid agonist rescues the metabolic syndrome phenotype of HO-2-null mice.

Authors:  Komal Sodhi; Kazuyoshi Inoue; Katherine H Gotlinger; Martina Canestraro; Luca Vanella; Dong Hyun Kim; Vijay L Manthati; Sreenivasulu Reddy Koduru; John R Falck; Michal L Schwartzman; Nader G Abraham
Journal:  J Pharmacol Exp Ther       Date:  2009-08-28       Impact factor: 4.030

10.  The Cyp2c44 epoxygenase regulates epithelial sodium channel activity and the blood pressure responses to increased dietary salt.

Authors:  Jorge H Capdevila; Nataliya Pidkovka; Shaojun Mei; Yan Gong; John R Falck; John D Imig; Raymond C Harris; Wenhui Wang
Journal:  J Biol Chem       Date:  2013-12-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.